JPH05306113A - Artificial particle - Google Patents

Artificial particle

Info

Publication number
JPH05306113A
JPH05306113A JP8723091A JP8723091A JPH05306113A JP H05306113 A JPH05306113 A JP H05306113A JP 8723091 A JP8723091 A JP 8723091A JP 8723091 A JP8723091 A JP 8723091A JP H05306113 A JPH05306113 A JP H05306113A
Authority
JP
Japan
Prior art keywords
particles
silica
water
soln
gelatin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP8723091A
Other languages
Japanese (ja)
Inventor
Ichiro Matsuda
一郎 松田
Ryuichi Fujino
隆一 藤野
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujirebio Inc
Original Assignee
Fujirebio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujirebio Inc filed Critical Fujirebio Inc
Priority to JP8723091A priority Critical patent/JPH05306113A/en
Publication of JPH05306113A publication Critical patent/JPH05306113A/en
Pending legal-status Critical Current

Links

Abstract

PURPOSE:To obtain artificial particles having a specified range of average particle size which are useful for agglutination immunoassay by mixing silica, gelatine, water-soluble polysaccharide and methaphosphate in a specified weight ratio. CONSTITUTION:Silica, gelatine, water-soluble polysaccharide (e.g. gum arabic) and methaphosphate (e.g. sodium trimethaphosphate) are mixed to obtain artificial particles having 0.5-10mum average particle size. The content of the mixture of gelatine, water-soluble polysaccharide and methaphosphate is 0.02-50mg/g based on silica. The production method of these particles is as follows. An aq. soln. of gelatine and aq. soln. of water-soluble polysaccharide are mixed with an aq. soln. of hydrophilic org. solvent while stirring, and further an aq. soln. of methaphosphate is added thereto. The mixed soln. is controlled to pH 5.5 to 8, and then a soln. containing silica is further added. The mixed soln. is controlled to pH 4 to 6.5 and then cooled.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、シリカ、ゼラチン、水
溶性多糖類及びメタリン酸塩を混合することにより得ら
れる粒子であって、その粒子中のゼラチン、水溶性多糖
類及びメタリン酸塩からなる混合物がシリカに対して、
0.02mg/g〜50mg/gであり、且つ得られる
粒子の平均粒子径が0.5μm〜10μmである人工粒
子に関する。この粒子は、例えば抗原又は抗体を結合さ
せ、凝集免疫測定に用いることができる。
FIELD OF THE INVENTION The present invention relates to particles obtained by mixing silica, gelatin, a water-soluble polysaccharide and a metaphosphate, wherein gelatin, water-soluble polysaccharide and metaphosphate are contained in the particles. To the silica mixture,
The present invention relates to artificial particles having an average particle size of 0.02 mg / g to 50 mg / g and an average particle size of the obtained particles of 0.5 μm to 10 μm. This particle can be used for an agglutination immunoassay by binding, for example, an antigen or an antibody.

【0002】[0002]

【従来の技術】従来より、免疫診断法の一つとして凝集
免疫測定法による診断法が知られている。その方法を実
施するには免疫活性物質例えば抗原、抗体等を結合させ
た粒子を用いて行うものである。この粒子としては、ポ
リスチレンラテックス、カオリン、炭末、動物赤血球、
細菌菌体等が知られ、用いられているのが現状である。
これら粒子は、入手が容易で大量に得ることができもの
の迅速測定にはむいていないこと、任意の一定の粒径の
ものが得にくいこと、製造ロットごとに性状が異なるこ
と、自然凝集や非特異凝集を起こしやすい等の欠点を有
しているため、改良が試みられているが、これら欠点を
克服するには至っていない。そこで、水溶性多糖類、ゼ
ラチン、メタリン酸ナトリウム及びアルデヒド架橋剤よ
りなる粒子(特公昭63−29223号、特公昭63−
48021号参照)等が見出された。
2. Description of the Related Art Conventionally, a diagnostic method based on an agglutination immunoassay is known as one of immunodiagnostic methods. The method is carried out by using particles to which an immunologically active substance such as an antigen or an antibody is bound. These particles include polystyrene latex, kaolin, charcoal powder, animal red blood cells,
At present, bacterial cells are known and used.
These particles are easy to obtain and can be obtained in large quantities, but they are not suitable for rapid measurement, it is difficult to obtain particles with an arbitrary fixed particle size, the properties differ from one production lot to another, spontaneous aggregation and non-aggregation Since it has drawbacks such as being likely to cause specific aggregation, attempts have been made to improve it, but these drawbacks have not been overcome yet. Therefore, particles composed of a water-soluble polysaccharide, gelatin, sodium metaphosphate and an aldehyde crosslinking agent (Japanese Examined Patent Publication Nos. 63-29223 and 63-63).
No. 48021) and the like were found.

【0004】[0004]

【発明が解決しようとする課題】しかしながら、この粒
子は、大量に任意の粒径で得られること等従来の粒子の
欠点の一部を解決できるようになったものの、迅速に凝
集免疫測定を行うことには対応できないでいた。
However, although this particle can solve some of the drawbacks of the conventional particles such as the fact that a large amount can be obtained with an arbitrary particle size, agglutination immunoassay can be carried out rapidly. I couldn't handle that.

【0005】[0005]

【課題を解決しようとする手段】本発明者等は、新たな
人工粒子について研究の結果、シリカ、ゼラチン、水溶
性多糖類及びメタリン酸塩を混合することにより得られ
る粒子が、従来の欠点を改良し迅速な凝集免疫測定法に
対応できることを見出し、本発明を完成したものであ
る。本発明は、シリカ、ゼラチン、水溶性多糖類及びメ
タリン酸塩を混合することにより得られる人工粒子であ
る。
As a result of research on new artificial particles, the present inventors found that particles obtained by mixing silica, gelatin, water-soluble polysaccharides and metaphosphates had the conventional drawbacks. The present invention has been completed by finding that it can be improved and can be applied to a rapid agglutination immunoassay. The present invention is an artificial particle obtained by mixing silica, gelatin, a water-soluble polysaccharide and a metaphosphate.

【0006】本発明の粒子は、シリカに水溶性多糖類、
ゼラチン及びメタリン酸塩を混合することにより得るこ
とができる。水溶性多糖類、ゼラチン及びメタリン酸塩
からなる混合物は、シリカに対して0.02mg/g〜
50mg/gであり、好ましくは1mg/g〜10mg
/gである。この混合物の量がシリカに対して0.02
mg/gより少ない時には、凝集免疫測定に使用した場
合表面に結合できる抗原又は抗体の量が少なく、測定の
感度を充分に上げることができない点で、またシリカに
対して50mg/gより多い場合には、粒子製造の際均
一な大きさの粒子を得ることができない点で好ましくな
い。
The particles of the present invention comprise silica, a water-soluble polysaccharide,
It can be obtained by mixing gelatin and metaphosphate. The mixture of water-soluble polysaccharide, gelatin and metaphosphate is 0.02 mg / g to silica.
50 mg / g, preferably 1 mg / g to 10 mg
/ G. The amount of this mixture is 0.02 with respect to silica.
When it is less than mg / g, the amount of antigen or antibody that can be bound to the surface is small when used for agglutination immunoassay, and the sensitivity of the measurement cannot be sufficiently increased, and when it is more than 50 mg / g for silica. In addition, it is not preferable because particles having a uniform size cannot be obtained during the production of particles.

【0007】混合され得られる粒子は、以下に記す操作
法を採用することによりその平均粒子径を0.5μm〜
10μmとすることができる。凝集免疫測定に用いる場
合には1μm〜5μmが好ましい。
The particles obtained by mixing have an average particle diameter of 0.5 .mu.m-by adopting the operation method described below.
It can be 10 μm. When used for agglutination immunoassay, 1 μm to 5 μm is preferable.

【0008】本発明の人工粒子は、シリカを含んでなる
ものである。シリカは、水又は水と混和性の有機溶媒中
アルカリ条件下でアルキルシリケートを加水分解をする
ことにより単分散のシリカ粒子として製造することがで
きる(日本化学会編、実験化学講座18巻、330〜3
31ページ参照)。アルキルシリケートとしては、市販
されているメチルシリケート、エチルシリケート(オル
トケイ酸エチル)等を用いることができる。製造される
シリカの大きさは、製造する際に添加するアルカリの量
により調整することができる。
The artificial particles of the present invention contain silica. Silica can be produced as monodisperse silica particles by hydrolyzing an alkyl silicate in water or an organic solvent that is miscible with water under alkaline conditions (edited by the Chemical Society of Japan, Experimental Chemistry Course, Vol. 18, 330). ~ 3
(See page 31). As the alkyl silicate, commercially available methyl silicate, ethyl silicate (ethyl orthosilicate) and the like can be used. The size of silica produced can be adjusted by the amount of alkali added during production.

【0009】また、本発明の粒子の製造に用いられる混
合物は、水溶性多糖類、ゼラチン及び、メタリン酸塩で
ある。水溶性多糖類としては、例えばアラビアゴム、カ
ルボキシメチルセルロース、アルギン酸ナトリウム、寒
天、カラゲーナン等を挙げることができるが、分散性よ
く安定な粒子を得ることができる点でアラビアゴムの使
用が好ましい。
The mixture used for producing the particles of the present invention is a water-soluble polysaccharide, gelatin and metaphosphate. Examples of the water-soluble polysaccharides include gum arabic, carboxymethyl cellulose, sodium alginate, agar, carrageenan, etc., but gum arabic is preferably used because stable particles can be obtained with good dispersibility.

【0010】ゼラチンは、通常市販のゼラチンを用いる
ことができるが、得られる粒子表面の電荷をコントロー
ルし均一な粒子とするために、等電点が8〜9である酸
処理ゼラチンの使用が好ましい。またメタリン酸塩とし
ては、例えば三メタリン酸ナトリウム、四メタリン酸ナ
トリウム、ヘキサメタリン酸ナトリウム、三メタリン酸
カリウム、四メタリン酸カリウム、ヘキサメタリン酸カ
リウム等を挙げることができるが、中でもヘキサメタリ
ン酸ナトリウムを使用することが好ましい。
As the gelatin, usually commercially available gelatin can be used, but in order to control the charge on the surface of the obtained particles and make the particles uniform, it is preferable to use acid-treated gelatin having an isoelectric point of 8-9. .. Examples of the metaphosphate include sodium trimetaphosphate, sodium tetrametaphosphate, sodium hexametaphosphate, potassium trimetaphosphate, potassium tetrametaphosphate, potassium hexametaphosphate, etc. Among them, sodium hexametaphosphate is used. Preferably.

【0011】人工粒子を製造する際、シリカに加えられ
る混合物は、親水性有機溶媒中で調整することができ
る。その際の各成分及び該溶媒の割合は、全体の溶液中
において水溶性多糖類0.05%〜2.0%好ましくは
0.1%〜1.0%、ゼラチン0.05%〜2.0%好
ましくは0.1%〜1.0%、親水性有機溶媒4%〜2
5%、メタリン酸塩は、ゼラチン乾燥重量の0.5%〜
20%(有機溶媒のみは容量%、他は重量%)で用いる
ことができ、必要に応じこの範囲で変えることができ
る。親水性有機溶媒としては、例えばメチルアルコー
ル、エチルアルコール、プロピルアルコール等のアルコ
ール類、アセトン、メチルエチルケトン等のケトン類を
挙げることができるが、これらアルコール類の中でもメ
チルアルコール、エチルアルコールの使用が好ましい。
The mixture added to the silica during the production of the artificial particles can be prepared in a hydrophilic organic solvent. The ratio of each component and the solvent at that time is 0.05% to 2.0% of the water-soluble polysaccharide, preferably 0.1% to 1.0%, and gelatin 0.05% to 2. 0%, preferably 0.1% to 1.0%, hydrophilic organic solvent 4% to 2
5%, metaphosphate is 0.5% to dry weight of gelatin
It can be used at 20% (volume% for organic solvent only, weight% for others), and can be changed within this range as necessary. Examples of the hydrophilic organic solvent include alcohols such as methyl alcohol, ethyl alcohol and propyl alcohol, and ketones such as acetone and methyl ethyl ketone. Among these alcohols, methyl alcohol and ethyl alcohol are preferably used.

【0012】人工粒子の製造には、親水性有機溶媒水溶
液に攪拌しながらゼラチン水溶液と水溶性多糖類水溶液
とを混合し、さらにメタリン酸塩水溶液を加え酸により
pH5.5〜8.0好ましくはpH6.0〜7.0に調
整し混合物溶液とする。さらにこの混合物溶液にシリカ
を含む溶液を加え攪拌した後、更に酸によりpH4.0
〜6.5好ましくはpH4.5〜5.5に調整し、冷却
することにより粒子を得ることができる。混合物溶液の
製造の際に用いられる各水溶液は、28〜60℃好まし
くは38〜40℃に加温して用いることができる。また
ゼラチン水溶液は、アルカリ水溶液でpH9付近に調整
して得られる均一溶液とし、水溶性多糖類水溶液は、水
に溶解したのち不純物があるときには除いておくことが
好ましい。製造にあたってpHの調整に用いられる酸は
有機酸、中でも酢酸を粒子の大きさを細かく調整するこ
とができる点で好適に用いることができる。
For the production of artificial particles, a gelatin aqueous solution and a water-soluble polysaccharide aqueous solution are mixed in a hydrophilic organic solvent aqueous solution with stirring, and a metaphosphate aqueous solution is further added to the mixture to give an acid having a pH of 5.5 to 8.0. The pH is adjusted to 6.0 to 7.0 to give a mixture solution. Further, a silica-containing solution was added to this mixed solution and stirred, and then the pH was adjusted to 4.0 with an acid.
To 6.5, preferably pH is adjusted to 4.5 to 5.5, and the particles can be obtained by cooling. Each aqueous solution used in the production of the mixture solution can be heated to 28 to 60 ° C., preferably 38 to 40 ° C. before use. The gelatin aqueous solution is preferably a uniform solution obtained by adjusting the pH to around 9 with an alkaline aqueous solution, and the water-soluble polysaccharide aqueous solution is preferably dissolved in water and then removed when impurities are present. The acid used for adjusting the pH in the production can be preferably an organic acid, especially acetic acid, since the particle size can be finely adjusted.

【0013】本発明のシリカ、水溶性多糖類、ゼラチン
及び、メタリン酸塩とからなる人工粒子を凝集免疫測定
用試薬として用いる場合には、さらに着色し、アルデヒ
ド化合物を作用させることもできる。得られた人工粒子
は、動物赤血球を担体とした場合と同様な方法(ボイデ
ン法;J.Exp.Med.,93,107〜120
(1950)等)に従い免疫活性物質、例えば抗原又は
抗体を結合させた後、凝集免疫測定用試薬とすることが
できる。
When the artificial particles composed of silica, water-soluble polysaccharides, gelatin and metaphosphate of the present invention are used as a reagent for agglutination immunoassay, they can be further colored and allowed to act with an aldehyde compound. The obtained artificial particles are treated in the same manner as in the case where animal red blood cells are used (Boyden method; J. Exp. Med., 93 , 107-120).
(1950) etc., an immunologically active substance, such as an antigen or an antibody, is bound thereto, and then used as a reagent for agglutination immunoassay.

【0014】[0014]

【実施例】以下実施例及び試験例により、本発明を更に
詳細に説明する。 (実施例1)フラスコにエタノール1400ml、蒸留
水520ml、25重量%のアンモニア水71ml及び
20mMの水酸化ナトリウム水溶液6mlを加え、室温
(20〜25℃)で5分間攪拌した後、オルトケイ酸エ
チル(和光純薬社製)500mlを375ml/時間の
速度で滴々添加し、シリカ粒子(平均粒子径3.04μ
m)を作った。得られたシリカ粒子をエタノールで遠心
分離による洗浄を繰り返すことにより精製されたシリカ
粒子を得た。シリカ粒子の粒子径は、表1に示すように
水酸化ナトリウム水溶液濃度により調整することができ
る。
EXAMPLES The present invention will be described in more detail with reference to the following examples and test examples. (Example 1) 1400 ml of ethanol, 520 ml of distilled water, 71 ml of 25 wt% ammonia water and 6 ml of 20 mM sodium hydroxide aqueous solution were added to the flask, and the mixture was stirred at room temperature (20 to 25 ° C) for 5 minutes, and then ethyl orthosilicate ( 500 ml of Wako Pure Chemical Industries, Ltd. was added dropwise at a rate of 375 ml / hour, and silica particles (average particle diameter 3.04μ)
m) made. The silica particles thus obtained were repeatedly washed with ethanol by centrifugation to obtain purified silica particles. The particle size of the silica particles can be adjusted by the concentration of the sodium hydroxide aqueous solution as shown in Table 1.

【0015】 表1 −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−− シリカ粒子 水酸化ナトリウム濃度(mM) シリカ粒子径(μm) −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−− シリカ粒子A 10 1.64 シリカ粒子B 15 2.64 シリカ粒子C 20 3.04 −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−Table 1 −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−− Silica particles Sodium hydroxide concentration (mM) Silica particle size ( μm) −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−− Silica particles A 10 1.64 Silica particles B 15 2.64 Silica particles C 20 3.04 --------------------------------------.

【0016】(実施例2)等電点が9であるゼラチン5
gを40℃の温水に100mlになるように溶解した。
アラビアゴム5gを水に溶解して100mlとし、不純
物を濾別した後、40℃に加温した。このようにして得
られたゼラチン水溶液40mlとアラビアゴム水溶液4
0mlを混合し、この混合液を予め40℃に加温した4
4容量%のエタノール水溶液504mlに注ぎ入れ、よ
く攪拌した。これに10%のヘキサメタリン酸ナトリウ
ム(和光純薬社製)水溶液20ml、10重量%アルキ
ルスルホマレイン酸(商品名デモールEP、花王石鹸社
製、登録商標)水溶液20ml、0.5%重量%の染料
であるニューフクシン(東京化成社製)水溶液40ml
を加えた後、10容量%酢酸水溶液を滴下してpH6.
0とした。次いで25容量%の実施例1で得られたシリ
カ粒子(シリカ粒子A、B又はC)水溶液400mlを
加え、良く攪拌した後に10容量%酢酸水溶液を滴下し
てpHを4.9に調整し、着色したシリカ、ゼラチン、
アラビアゴム及びヘキサメタリン酸ナトリウムを含む粒
子を得た。
(Example 2) Gelatin 5 having an isoelectric point of 9
g was dissolved in warm water at 40 ° C. so as to be 100 ml.
5 g of gum arabic was dissolved in water to 100 ml, impurities were filtered off, and the mixture was heated to 40 ° C. 40 ml of the aqueous gelatin solution thus obtained and the aqueous solution of gum arabic 4
0 ml was mixed, and this mixture was preheated to 40 ° C. 4
It was poured into 504 ml of a 4% by volume aqueous ethanol solution and stirred well. 20 ml of a 10% aqueous solution of sodium hexametaphosphate (manufactured by Wako Pure Chemical Industries, Ltd.), 20 ml of an aqueous solution of 10% by weight of alkylsulfomaleic acid (trade name: Demol EP, registered trademark of Kao Soap Co., Ltd.), and a dye of 0.5% by weight 40 ml of New Fuchsin (Tokyo Kasei) aqueous solution
After the addition of 10% by volume of acetic acid aqueous solution, the pH was adjusted to 6.
It was set to 0. Next, 400 ml of a 25% by volume aqueous solution of the silica particles (silica particles A, B or C) obtained in Example 1 was added, and after stirring well, a 10% by volume aqueous acetic acid solution was added dropwise to adjust the pH to 4.9, Colored silica, gelatin,
Particles containing gum arabic and sodium hexametaphosphate were obtained.

【0017】このpH調整によって得られた粒子分散液
を氷冷して5℃にしてから、25容量%のグルタルアル
デヒド水溶液8mlを加え、よく攪拌後この温度で二夜
静置し、粒子を不溶化した。それからこの粒子分散液を
2000rpmで5分間遠心分離して粒子をペレットと
して回収した。この粒子を0.01%デモールEP溶液
に懸濁して遠心分離する洗浄操作を3回繰り返してか
ら、4容量%のホルマリン水溶液に分散し、5℃で1週
間放置することにより着色した人工粒子A、B又はCを
得た。
The particle dispersion obtained by this pH adjustment was ice-cooled to 5 ° C., 8 ml of a 25% by volume glutaraldehyde aqueous solution was added, and after stirring well, the mixture was allowed to stand at this temperature for two nights to insolubilize the particles. did. The particle dispersion was then centrifuged at 2000 rpm for 5 minutes to collect the particles as pellets. The washing operation of suspending these particles in a 0.01% demol EP solution and centrifuging was repeated three times, and then dispersed in a 4% by volume aqueous formalin solution, and allowed to stand at 5 ° C. for 1 week to give colored artificial particles A. , B or C were obtained.

【0018】(実施例3)等電点が9であるゼラチン5
gを40℃の温水に100mlになるように溶解した。
アラビアゴム5gを100mlになるように水に溶解
し、不純物を濾別した後、40℃に加温した。このよう
にして得られたゼラチン水溶液0.5mlとアラビアゴ
ム水溶液0.5mlを混合し、この混合液を予め40℃
に加温した41容量%のエタノール溶液272mlに注
ぎ入れ、よく攪拌した。これに10%のヘキサメタリン
酸ナトリウム水溶液2.0ml、10重量%のデモール
EP水溶液20ml、10容量%酢酸水溶液を滴下して
pH6.0とした。次いで25容量%の実施例2で得ら
れた人工粒子(粒子A、B及びC)水溶液200mlを
加え、良く攪拌した後に10容量%酢酸水溶液を滴下し
てpHを4.9に調整した。得られた粒子分散液を氷冷
して5℃にしてから、25容量%のグルタルアルデヒド
水溶液2.0mlを加え、よく攪拌後この温度で二夜静
置し、粒子を不溶化した。更に実施例2と同じ操作によ
り粒子を回収した。得られた人工粒子A,B又はCの粒
子径を表2に示す。平均粒子径は、コールターカウンタ
ーTAII(日科機社製)により測定し求めることができ
る。比較としてヒツジ赤血球及びゼラチン粒子の測定結
果を示す。
(Example 3) Gelatin 5 having an isoelectric point of 9
g was dissolved in warm water at 40 ° C. so as to be 100 ml.
5 g of gum arabic was dissolved in 100 ml of water, impurities were filtered off, and the mixture was heated to 40 ° C. 0.5 ml of the aqueous gelatin solution thus obtained and 0.5 ml of the aqueous solution of gum arabic were mixed, and the mixture was preheated at 40 ° C.
It was poured into 272 ml of a 41% by volume ethanol solution which had been warmed up and stirred well. To this, 2.0 ml of 10% sodium hexametaphosphate aqueous solution, 20 ml of 10% by weight demole EP aqueous solution and 10% by volume aqueous acetic acid solution were added dropwise to adjust the pH to 6.0. Next, 200 ml of 25% by volume of the aqueous solution of the artificial particles (particles A, B and C) obtained in Example 2 was added, and after stirring well, a 10% by volume acetic acid aqueous solution was added dropwise to adjust the pH to 4.9. The obtained particle dispersion liquid was ice-cooled to 5 ° C., 2.0 ml of a 25% by volume aqueous glutaraldehyde solution was added, and the mixture was well stirred and left at this temperature for two nights to insolubilize the particles. Further, the particles were recovered by the same operation as in Example 2. Table 2 shows the particle sizes of the obtained artificial particles A, B or C. The average particle diameter can be determined by measuring with a Coulter Counter TAII (manufactured by Nikkaki Co., Ltd.). For comparison, the measurement results of sheep red blood cells and gelatin particles are shown.

【0019】 [0019]

【0020】各ゼラチン濃度による、ゼラチン、アラビ
アゴム、ヘキサメタリン酸ナトリウムからなる混合物と
シリカ粒子とからなる人工粒子の混合割合及び凝集免疫
測定用粒子の性状の一つである自然凝集の有無について
の検討を行った。そのシリカ粒子に対する混合物との混
合割合及び自然凝集の検討結果を表3に示す。混合物の
量は、反応容器中に加えた混合物の量から、シリカを加
え反応したのち溶液中から減少した混合物の量から求め
ることができる。
Examination of the mixing ratio of artificial particles composed of a mixture of gelatin, gum arabic, sodium hexametaphosphate and silica particles and the presence or absence of spontaneous aggregation, which is one of the properties of the particles for agglutination immunoassay, depending on the concentration of each gelatin. I went. Table 3 shows the examination results of the mixing ratio of the mixture with respect to the silica particles and the spontaneous aggregation. The amount of the mixture can be determined from the amount of the mixture added to the reaction vessel, and the amount of the mixture decreased from the solution after the reaction by adding silica.

【0021】 表3 −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−− ゼラチン濃度 シリカ粒子に対する混合物 人工粒子の (%) の割合 (mg/g) 自然凝集 −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−− 0.80 20.6 有 0.40 9.0 有 0.20 4.0 無 0.10 1.3 無 0.05 0.1 無 −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−Table 3 ------------------ Gelatin Concentration Mixture for Silica Particles of Artificial Particles Ratio of (%) (mg / g) Spontaneous aggregation −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−− 0. 80 20.6 Yes 0.40 9.0 Yes 0.20 4.0 No 0.10 1.3 No 0.05 0.1 No ----------------------- −−−−−−−−−−−−−−−−−−−

【0022】(試験例)リウマチ因子の測定試験 実施例3で得られた人工粒子A、B又はCを濃度が5%
になるようにpH7.2のリン酸塩緩衝生理食塩水(以
下PBSという)に分散し、その20mlを5ppmの
タンニン酸を含むPBS(pH7.2)20mlと混合
した。この混合液を37℃で10分間加温後、遠心分離
して生理食塩水で充分洗浄してから5%になるようにP
BS(pH6.4)に分散し、全量を20mlとした。
一方pH6.4のPBS中に浮遊させた熱変性ウサギポ
リマーIgG分画を感作液とした。
(Test Example) Rheumatoid Factor Measurement Test The artificial particles A, B or C obtained in Example 3 were used at a concentration of 5%.
To a pH 7.2 of phosphate buffered saline (hereinafter referred to as PBS), and 20 ml thereof was mixed with 20 ml of PBS (pH 7.2) containing 5 ppm of tannic acid. After heating this mixture at 37 ° C for 10 minutes, centrifuge it and wash it thoroughly with physiological saline.
It was dispersed in BS (pH 6.4) to make the total amount 20 ml.
On the other hand, a heat-denatured rabbit polymer IgG fraction suspended in PBS of pH 6.4 was used as a sensitizing solution.

【0023】タンニン酸処理粒子分散液20mlと感作
液20mlとを混合して37℃で60分間加温した。こ
のようにして得られた感作人工粒子をpH6.4のPB
Sで充分洗浄し、粒子濃度が5%になるように19ml
の分散用メディウムに分散して凍結乾燥した。この凍結
乾燥品に蒸留水を加え凍結乾燥前と同容量になるよう復
元し、各血清についてマイクロタイター法による受身凝
集反応で測定した。実施例3で得られた感作人工粒子
A、B又はCから製造した抗原結合人工粒子を用いて測
定を行い、測定結果を得るために必要な時間(判定時
間)を表4に示す。比較のため感作ゼラチン粒子(製品
名:セロディア(登録商標)RA;富士レビオ社製)、
ヒツジ赤血球に熱変性ウサギポリマーIgG分画をタン
ニン酸を用いた常法により結合させて製造した感作ヒツ
ジ赤血球による判定時間を表4に示す。
20 ml of the tannic acid-treated particle dispersion liquid and 20 ml of the sensitizing liquid were mixed and heated at 37 ° C. for 60 minutes. The sensitized artificial particles thus obtained were mixed with PB of pH 6.4.
Thoroughly wash with S, 19ml so that the particle concentration becomes 5%
And was lyophilized. Distilled water was added to this lyophilized product to restore it to the same volume as before lyophilization, and each serum was measured by passive agglutination reaction by the microtiter method. Table 4 shows the time (judgment time) required to obtain the measurement result by performing measurement using the antigen-bound artificial particle produced from the sensitized artificial particle A, B or C obtained in Example 3. For comparison, sensitized gelatin particles (product name: Cellodia (registered trademark) RA; manufactured by Fujirebio Co., Ltd.),
Table 4 shows the determination times for sensitized sheep erythrocytes produced by binding heat-denatured rabbit polymer IgG fractions to sheep erythrocytes by a conventional method using tannic acid.

【0024】 [0024]

【0025】また、陽性血清及び陰性血清について各粒
子を用いマイクロタイター法による受身凝集反応で力価
の測定をした。その結果を表5に示す。 表5 −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−− 血清 血清希釈倍率(×40) サンプル 粒子 −−−−−−−−−−−−−−−−−−−−−−−−−− 1 2 4 8 16 32 64 128 256 −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−− 陽性 人工粒子C + + + + + + + + − 陽性 ゼラチン粒子 + + + + + + + + − 陽性 ヒツジ赤血球 + + + + + + + + − −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−− 陰性 人工粒子C − − − − − − − − − 陰性 ゼラチン粒子 − − − − − − − − − 陰性 ヒツジ赤血球 − − − − − − − − − −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−− +:陽性判定 −:陰性判定
Further, the titer of the positive serum and the negative serum was measured by a passive agglutination reaction by the microtiter method using each particle. The results are shown in Table 5. Table 5 ------------------------- Serum Serum Dilution Ratio (x40) Sample Particles --- −−−−−−−−−−−−−−−−−−−−−−− 1 2 4 8 16 32 32 64 128 256 −−−−−−−−−−−−−−−−−− −−−−−−−−−−−−−−−−−−− Positive artificial particles C + + + + + + + + + − Positive gelatin particles + + + + + + + + + + − Positive sheep red blood cells + + + + + + + + − −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−− Negative Artificial Particle C −−−− − − − − − Negative gelatin particles − − − − − − − − − Negative sheep red blood cell − − − − − − − − − −−−−−−−−−−−−−−−−−−−−−− −−−−−−−−−−−−− - +: Positive decision -: negative decision

【0026】[0026]

【発明の効果】本発明は、シリカ、ゼラチン、水溶性多
糖類及びメタリン酸塩とを混合することにより得られる
新たな人工粒子である。例えば、この粒子に抗原又は抗
体を結合させて凝集免疫測定用試薬として用いると15
分で結果を得ることができ、迅速な測定が可能である。
さらに非特異凝集を起こすことなく正確な測定をするこ
とができる。
The present invention is a new artificial particle obtained by mixing silica, gelatin, a water-soluble polysaccharide and a metaphosphate. For example, when an antigen or antibody is bound to these particles and used as a reagent for agglutination immunoassay, 15
The result can be obtained in minutes, and quick measurement is possible.
Further, accurate measurement can be performed without causing nonspecific aggregation.

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】シリカ、ゼラチン、水溶性多糖類及びメタ
リン酸塩を混合することにより得られる粒子であって、
その粒子中のゼラチン、水溶性多糖類及びメタリン酸塩
からなる混合物がシリカに対して、0.02mg/g〜
50mg/gであり、且つ得られる粒子の平均粒子径が
0.5μm〜10μmであることを特徴とする人工粒
子。
1. Particles obtained by mixing silica, gelatin, a water-soluble polysaccharide and a metaphosphate,
The mixture of gelatin, water-soluble polysaccharides and metaphosphate in the particles is 0.02 mg / g to silica.
50 mg / g, and the obtained particles have an average particle diameter of 0.5 μm to 10 μm.
【請求項2】水溶性多糖類が、アラビアゴムである請求
項1記載の人工粒子。
2. The artificial particle according to claim 1, wherein the water-soluble polysaccharide is gum arabic.
JP8723091A 1991-03-28 1991-03-28 Artificial particle Pending JPH05306113A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP8723091A JPH05306113A (en) 1991-03-28 1991-03-28 Artificial particle

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8723091A JPH05306113A (en) 1991-03-28 1991-03-28 Artificial particle

Publications (1)

Publication Number Publication Date
JPH05306113A true JPH05306113A (en) 1993-11-19

Family

ID=13909060

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8723091A Pending JPH05306113A (en) 1991-03-28 1991-03-28 Artificial particle

Country Status (1)

Country Link
JP (1) JPH05306113A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000036066A1 (en) * 1998-12-16 2000-06-22 Unilever N.V. Polymer-containing particle and process for the preparation thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000036066A1 (en) * 1998-12-16 2000-06-22 Unilever N.V. Polymer-containing particle and process for the preparation thereof

Similar Documents

Publication Publication Date Title
US4416813A (en) Artificial carrier for immobilization of biological proteins
DE2203377C3 (en) Water-insoluble immunological diagnostic reagent intended for an agglutination test
Bozicevich et al. A rapid flocculation test for the diagnosis of trichinosis
US4060597A (en) Serological reagent and preparation thereof
JP2896174B2 (en) Artificial carrier
JPS6161062B2 (en)
JPH0317103B2 (en)
JPH05306113A (en) Artificial particle
EP0062968B2 (en) Support material for use in serological testing and process for the production thereof
US3840655A (en) Diagnostic methods and reagents for infectous mononucleosis
KR920002183B1 (en) Reagent for use in detecting antibody to human t-cell leukaemia virus antigen
Ben-Shaul et al. Age-dependent differences in cognin regeneration on embryonic retina cells: immunolabeling and SEM studies
JP2000292420A (en) Method for sampling serum or plasma and reagent for separating serum or plasma
JPS6022664A (en) Method for diagnosing mastitis by lactoferrin, diagnosing reagent and reagent kit for diagnosis
JP3040224B2 (en) Method for producing immunological agglutination particles
JPS6332146B2 (en)
US3697639A (en) Serological test for the detection of hepatitis
JP3033774B2 (en) Indirect agglutination reagent for detection of adult T-cell leukemia virus antibody
JP2512627B2 (en) Method for producing immunological agglutination reagent for long-term storage stability, and liquid for dissolving immunological agglutination particles used therefor
JPH06130060A (en) Method for increasing specific gravity of particle for particle immunity measurement
JPS5935143A (en) Carrier for immobilizing actic protein
RU2139539C1 (en) Method of treponema antigenic diagnosticum preparing
JP2584924B2 (en) Method for producing immunological agglutination particles
JPH0743383B2 (en) Carrier latex for diagnostic reagents
JPH04166767A (en) Gelatin coated particle